Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 8451-8500 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT05463952
A Study to Learn About the Vepdegestrant (ARV-471, PF-07850327) in People With ER+/HER2- Locally Advanced or Metastatic Breast Cancer (BC)
PHASE1Active, not recruiting
6 participants
Started: Aug 16, 2022 · Completed: Mar 31, 2025
1 condition2 sponsors3 locations
NCT03915691
The RIPPLE AT-PLUS Study
NAActive, not recruiting
201 participants
Started: Aug 16, 2022 · Completed: Apr 30, 2026
1 condition8 sponsors3 locations
NCT04306315
Adjusted Brodalumab Dose Compared With Standard Brodalumab Dose in Subjects With Moderate-to-severe Plaque Psoriasis and ≥120 kg Body Weight
PHASE4Active, not recruiting
385 participants
Started: Aug 16, 2022 · Completed: Dec 29, 2025
1 condition1 sponsor81 locations
NCT05305365
Study Assessing QBS72S For Treating Brain Metastases
PHASE2Active, not recruiting
21 participants
Started: Aug 16, 2022 · Completed: Nov 30, 2025
5 conditions2 sponsors1 location
NCT05501717
Safety, PK/PD, and Immunogenicity Study of SC ALXN2030 in Healthy Participants
PHASE1Active, not recruiting
48 participants
Started: Aug 16, 2022 · Completed: Oct 30, 2026
1 condition1 sponsor1 location
NCT05469698
Onsite Tobacco Cessation Treatment for Patients With PAD
NAActive, not recruiting
15 participants
Started: Aug 16, 2022 · Completed: Jul 31, 2024
2 conditions1 sponsor1 location
NCT05502341
Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen
PHASE2/PHASE3Active, not recruiting
689 participants
Started: Aug 16, 2022 · Completed: Jul 31, 2028
1 condition1 sponsor94 locations
NCT05489926
A Study to Explore Pamiparib Treatment in Epithelial Ovarian Cancer After Prior PARP Inhibitor Exposure
PHASE2Active, not recruiting
15 participants
Started: Aug 16, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT06522971
Effects of Physical Exercise on Response to Treatement in Breast Cancer
NAActive, not recruiting
55 participants
Started: Aug 16, 2022 · Completed: Dec 30, 2027
1 condition3 sponsors1 location
NCT07213726
Quantification of Progenitor Cell Circulation Following Vascular Resistance Exercise Using Delfi Tourniquet System
NAActive, not recruiting
15 participants
Started: Aug 16, 2022 · Completed: Nov 20, 2026
1 condition2 sponsors1 location
NCT05393284
Phase 2 Spectra Study to Evaluate the Safety and Efficacy of OPL-0401 in Patients With Diabetic Retinopathy
PHASE2Active, not recruiting
114 participants
Started: Aug 16, 2022 · Completed: Aug 31, 2024
2 conditions1 sponsor25 locations
NCT05494606
An Observational Study to Assess Change in Disease Activity and Adverse Events of Upadacitinib in Adult Participants With Moderate to Severe Ulcerative Colitis (UC) in Real-World Practice
N/AActive, not recruiting
785 participants
Started: Aug 15, 2022 · Completed: Mar 31, 2028
1 condition1 sponsor153 locations
NCT05227677
Value of Glycated Albumin in Intervention of Glycemic Control in Chinese Patients With Type 2 Diabetes
NAActive, not recruiting
200 participants
Started: Aug 15, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor7 locations
NCT05452642
The Supporting Understanding of PCOS Education and Research (SUPER) Study
NAActive, not recruiting
223 participants
Started: Aug 15, 2022 · Completed: Jul 15, 2026
1 condition2 sponsors1 location
NCT05479552
A Diagnostic Test for Dementia With Lewy Bodies
N/AActive, not recruiting
80 participants
Started: Aug 15, 2022 · Completed: Oct 31, 2025
2 conditions2 sponsors12 locations
NCT06412523
Device-related Central Nervous System Infections in Adult Intensive Care Units in Brazil
N/AActive, not recruiting
554 participants
Started: Aug 15, 2022 · Completed: Jun 30, 2024
1 condition1 sponsor18 locations
NCT05291234
A Study to Assess Safety of ABBV-916 and How Intravenous ABBV-916 Moves Through Body and Affects Brain Amyloid Plaque Clearance in Adult Participants (Aged 50-90 Years) With Early Alzheimer's Disease
PHASE2Active, not recruiting
106 participants
Started: Aug 15, 2022 · Completed: Nov 30, 2025
1 condition1 sponsor32 locations
NCT05505084
Alveolar Ridge Preservation Following Tooth Extraction.
N/AActive, not recruiting
50 participants
Started: Aug 15, 2022 · Completed: Dec 31, 2025
3 conditions2 sponsors1 location
NCT05419388
A Study of Multiple Doses of RO7247669 in Participants With Previously Untreated Unresectable or Metastatic Melanoma
PHASE1/PHASE2Active, not recruiting
93 participants
Started: Aug 15, 2022 · Completed: Nov 30, 2025
1 condition1 sponsor22 locations
NCT05548075
Psilocybin in Patients With Fibromyalgia: EEG-measured Brain Biomarkers of Action
N/AActive, not recruiting
20 participants
Started: Aug 15, 2022 · Completed: Jul 30, 2024
1 condition1 sponsor1 location
NCT05139160
Aminoacidemia and Protein Kinetics in Response to the Ingestion of Plant-based Protein Blends
NAActive, not recruiting
8 participants
Started: Aug 15, 2022 · Completed: Jul 10, 2025
1 condition1 sponsor1 location
NCT05417698
Evaluation of Lifestyle Modification on Cardiovascular Risk
NAActive, not recruiting
60 participants
Started: Aug 15, 2022 · Completed: Aug 15, 2025
5 conditions1 sponsor1 location
NCT04956354
The Use of Wireless Sensors in Neonatal Intensive Care
N/AActive, not recruiting
75 participants
Started: Aug 15, 2022 · Completed: Jul 31, 2026
2 conditions3 sponsors1 location
NCT05913869
Online Mindfulness-based Program for Parents of Children With Autism
NAActive, not recruiting
24 participants
Started: Aug 15, 2022 · Completed: Dec 30, 2025
3 conditions1 sponsor1 location
NCT06240624
Mapping Levodopa Effects on Cortico-basal Ganglia Circuit Function in Parkinson's Disease
N/AActive, not recruiting
75 participants
Started: Aug 15, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05058638
Effectiveness of Aquamin® in Mitigating Halitosis
PHASE2Active, not recruiting
15 participants
Started: Aug 15, 2022 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT05459961
Metabolic Responses to Spermidine Supplementation.
NAActive, not recruiting
42 participants
Started: Aug 14, 2022 · Completed: Feb 28, 2025
1 condition1 sponsor1 location
NCT05367544
Equity in Prevention and Progression of Hypertension by Addressing Barriers to Nutrition and Physical activitY
NAActive, not recruiting
528 participants
Started: Aug 13, 2022 · Completed: Sep 30, 2026
3 conditions1 sponsor1 location
NCT05473923
PTCs-based Precision Treatment Strategy on Recurrent High-grade Gliomas
EARLY_PHASE1Active, not recruiting
30 participants
Started: Aug 12, 2022 · Completed: Jun 30, 2025
1 condition2 sponsors1 location
NCT05456087
Use of Botulinum Toxin in the Treatment of Androgenic Alopecia
PHASE2Active, not recruiting
20 participants
Started: Aug 12, 2022 · Completed: Dec 31, 2024
1 condition2 sponsors1 location
NCT04574518
Teachable Moment to Opt-out of Tobacco: Interactive Voice Response Quit Line for Veteran Active Smokers With Lung Nodules
NAActive, not recruiting
223 participants
Started: Aug 12, 2022 · Completed: Sep 30, 2025
3 conditions3 sponsors3 locations
NCT05524883
Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-251 in Participants With Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping
PHASE1/PHASE2Active, not recruiting
86 participants
Started: Aug 12, 2022 · Completed: Nov 30, 2029
1 condition1 sponsor30 locations
NCT05494632
Interaural Frequency and Loudness Mismatch in SSD CI Users
NAActive, not recruiting
45 participants
Started: Aug 12, 2022 · Completed: Aug 1, 2025
1 condition2 sponsors1 location
NCT06353490
The Clinical Performance Validation of Electronic Thermometer and Infrared Thermometers
NAActive, not recruiting
150 participants
Started: Aug 12, 2022 · Completed: Aug 11, 2024
2 conditions1 sponsor2 locations
NCT05327257
iTBS rTMS in Mild Cognitive Impairment
NAActive, not recruiting
25 participants
Started: Aug 11, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05061134
A Study of Ceralasertib Monotherapy and Ceralasertib Plus Durvalumab in Patients With Melanoma and Resistance to PD-(L)1 Inhibition
PHASE2Active, not recruiting
194 participants
Started: Aug 11, 2022 · Completed: Nov 2, 2026
1 condition1 sponsor66 locations
NCT05392946
Iberdomide, Daratumumab, Bortezomib, and Dexamethasone for Treatment of Newly Diagnosed Multiple Myeloma, IDEAL Study
PHASE1/PHASE2Active, not recruiting
49 participants
Started: Aug 11, 2022 · Completed: May 31, 2028
1 condition1 sponsor1 location
NCT05007821
Linezolid Dosing Strategies in Drug-Resistant TB
PHASE2Active, not recruiting
138 participants
Started: Aug 11, 2022 · Completed: Mar 13, 2026
3 conditions1 sponsor13 locations
NCT05468697
A Study of Belzutifan (MK-6482) in Combination With Palbociclib Versus Belzutifan Monotherapy in Participants With Advanced Renal Cell Carcinoma (MK-6482-024/LITESPARK-024)
PHASE1/PHASE2Active, not recruiting
210 participants
Started: Aug 10, 2022 · Completed: Jul 21, 2026
1 condition1 sponsor13 locations
NCT06548893
Acceptance and Commitment Therapy (ACT) in Groups for Obsessive Compulsive Disorder: A Clinical Trial in Brazil
NAActive, not recruiting
24 participants
Started: Aug 10, 2022 · Completed: Jun 20, 2026
1 condition1 sponsor1 location
NCT05371080
A Study on the Long-term Efficacy, Safety and Persistence of Immune Response of a Vaccine Against Herpes Zoster in Older Adults
PHASE3Active, not recruiting
3,038 participants
Started: Aug 10, 2022 · Completed: Aug 23, 2027
1 condition1 sponsor107 locations
NCT05782374
Real World Data on Ibrutinib Use in PCNSL Rel/Ref
N/AActive, not recruiting
36 participants
Started: Aug 10, 2022 · Completed: Aug 10, 2026
1 condition1 sponsor1 location
NCT05330325
A Research Study to Compare Somapacitan Once a Week With Norditropin® Once a Day in Children Who Need Help to Grow
PHASE3Active, not recruiting
399 participants
Started: Aug 10, 2022 · Completed: Oct 29, 2027
1 condition1 sponsor165 locations
NCT05607810
Long-Term Follow-up Study of ADVM-022 in DME (INFINITY-EXT)
N/AActive, not recruiting
22 participants
Started: Aug 10, 2022 · Completed: Apr 30, 2026
2 conditions1 sponsor7 locations
NCT05192486
A Study of GNC-038, a Tetra-specific Antibody, in Participants With R/R Diffuse Large B-cell Lymphoma (DLBCL)
PHASE1/PHASE2Active, not recruiting
12 participants
Started: Aug 10, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors4 locations
NCT05391178
Improving Disease Severity
NAActive, not recruiting
13 participants
Started: Aug 9, 2022 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT05274243
2-HOBA Phase 2 Clinical Trial in Rheumatoid Arthritis
PHASE2Active, not recruiting
32 participants
Started: Aug 9, 2022 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT05507424
Prone Positioning During Delayed Cord Clamping
NAActive, not recruiting
89 participants
Started: Aug 9, 2022 · Completed: Aug 31, 2028
1 condition2 sponsors2 locations
NCT05459571
Study of Axicabtagene Ciloleucel Given With Steroids In Participants With Relapsed Or Refractory Large B-Cell Lymphoma
PHASE2Active, not recruiting
30 participants
Started: Aug 9, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor16 locations
NCT05396885
Study of Anitocabtagene-autoleucel in Relapsed or Refractory Multiple Myeloma (iMMagine-1)
PHASE2Active, not recruiting
129 participants
Started: Aug 9, 2022 · Completed: Dec 31, 2026
1 condition2 sponsors18 locations